Literature DB >> 20395431

Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma.

Matthias Zenkel1, Piotr Lewczuk, Anselm Jünemann, Friedrich E Kruse, Gottfried O H Naumann, Ursula Schlötzer-Schrehardt.   

Abstract

Pseudoexfoliation (PEX) syndrome, which is an age-related, generalized elastotic matrix process, currently represents the most common identifiable risk factor for open-angle glaucoma. Dysregulated expression of proinflammatory cytokines has been implicated in the initiation of various fibrotic disorders and in the pathophysiology of glaucoma. Here we investigated the presence, expression, regulation, and functional significance of proinflammatory cytokines in eyes with early and late stages of PEX syndrome/glaucoma in comparison with normal and glaucomatous control eyes using multiplex bead analysis, immunoassays, real-time PCR, Western blotting, immunohistochemistry, and cell culture models. Early stages of PEX syndrome were characterized by approximately threefold (P < 0.005) elevated interleukin (IL)-6 and IL-8 levels in the aqueous humor and a concomitant approximately twofold (P < 0.001) increase in mRNA expression levels in anterior segment tissues as compared with controls. In contrast, late stages of PEX syndrome/glaucoma did not differ significantly from controls. IL-6, IL-6 receptor, and phospho-signal transducer and activator of transcription 3 could be mainly localized to walls of iris vessels and to the nonpigmented epithelium of ciliary processes. IL-6 and IL-8 were significantly up-regulated by ciliary epithelial cells in response to hypoxia or oxidative stress in vitro, whereas IL-6, but not IL-8, induced the expression of transforming growth factor-beta1 and elastic fiber proteins. These findings support a role for a stress-induced, spatially, and temporally restricted subclinical inflammation in the onset of the fibrotic matrix process characteristic of PEX syndrome/glaucoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395431      PMCID: PMC2877848          DOI: 10.2353/ajpath.2010.090914

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.

Authors:  Matthias Zenkel; Friedrich E Kruse; Anselm G Jünemann; Gottfried O H Naumann; Ursula Schlötzer-Schrehardt
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study.

Authors:  T Hammer; U Schlötzer-Schrehardt; G O Naumann
Journal:  Arch Ophthalmol       Date:  2001-07

3.  IL-6 increases endothelial permeability in vitro.

Authors:  N Maruo; I Morita; M Shirao; S Murota
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

4.  8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome.

Authors:  G G Koliakos; A G P Konstas; U Schlötzer-Schrehardt; G Hollo; I E Katsimbris; N Georgiadis; R Ritch
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

5.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

Authors:  I L Campbell; C R Abraham; E Masliah; P Kemper; J D Inglis; M B Oldstone; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.

Authors:  Somnath Banerjee; Vijay Savant; Robert A H Scott; S John Curnow; Graham R Wallace; Philip I Murray
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

7.  Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice.

Authors:  L R Luckett-Chastain; R M Gallucci
Journal:  Br J Dermatol       Date:  2009-04-29       Impact factor: 9.302

8.  Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.

Authors:  Ursula Schlötzer-Schrehardt; Francesca Pasutto; Pascal Sommer; Ian Hornstra; Friedrich E Kruse; Gottfried O H Naumann; André Reis; Matthias Zenkel
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

9.  Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma.

Authors:  Matthias Zenkel; Friedrich E Kruse; Gottfried O H Naumann; Ursula Schlötzer-Schrehardt
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

Review 10.  A new direction in the pathogenesis of idiopathic pulmonary fibrosis?

Authors:  Jack Gauldie; Martin Kolb; Patricia J Sime
Journal:  Respir Res       Date:  2001-09-26
View more
  47 in total

Review 1.  Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.

Authors:  Teresa Borrás
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

2.  Is there an association between pseudoexfoliation syndrome and knee osteoarthritis?

Authors:  M Ucar; U Sarp; K Kirboga; M Adam; H O Arik; F Gundogdu
Journal:  Z Rheumatol       Date:  2015-11       Impact factor: 1.372

3.  YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome.

Authors:  Tansu Gonen; Savas Guzel; Kadircan H Keskinbora
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

4.  Isoforms of TGF-β in the aqueous humor of patients with pseudoexfoliation syndrome and a possible association with the long-term stability of the capsular bag after cataract surgery.

Authors:  Justus G Garweg; Souska Zandi; Christin Gerhardt; Isabel B Pfister
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-28       Impact factor: 3.117

5.  Infection of endotheliotropic human cytomegalovirus of trabecular meshwork cells.

Authors:  Daisuke Shimizu; Dai Miyazaki; Yumiko Shimizu; Mayumi Hosogai; Isao Kosugi; Yoshitsugu Inoue
Journal:  Jpn J Ophthalmol       Date:  2018-09-06       Impact factor: 2.447

Review 6.  [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].

Authors:  U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

Review 7.  Is Autophagy Dysfunction a Key to Exfoliation Glaucoma?

Authors:  J Mario Wolosin; Robert Ritch; Audrey M Bernstein
Journal:  J Glaucoma       Date:  2018-03       Impact factor: 2.503

8.  Nitric oxide and tumour necrosis factor alpha in the process of pseudoexfoliation glaucoma.

Authors:  Tatjana S Sarenac Vulovic; Sladjana M Pavlovic; Vladimir Lj Jakovljevic; Katarina B Janicijevic; Nemanja S Zdravkovic
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

9.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

Review 10.  Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.

Authors:  Audrey M Bernstein; Robert Ritch; Jose M Wolosin
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.